| View |
|
DRP-13665-03
|
Cefixime (as trihydrate)
|
Techmecef
|
200 mg
|
Dispersible Tablet (Trusil Strawberry Flavor)
|
Antibacterial (Cephalosporin)
|
Innova Captab Ltd.
|
India
|
CLIDP Conversion
|
24 September 2024
|
23 March 2028
|
| View |
|
DRP-13687-08
|
Losartan Potassium
|
Zelosart-50
|
50 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
15 September 2024
|
28 March 2028
|
| View |
|
DRP-13700-01
|
Alfuzosin hydrochloride
|
None
|
10 mg
|
Extended-Release Tablet
|
Alpha-adrenoreceptor Antagonist
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
27 September 2024
|
29 March 2028
|
| View |
|
DRP-13687-10
|
Losartan Potassium
|
Potazar
|
50 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
15 September 2024
|
28 March 2028
|
| View |
|
DRP-13686-08
|
Losartan Potassium
|
Leesartan 100
|
100 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
27 September 2024
|
28 March 2028
|
| View |
|
DRP-14065-07
|
Ceftriaxone (as sodium)
|
None
|
1 g
|
Powder for Injection (IM/IV)
|
Antibacterial (Cephalosporin)
|
Swiss Parenterals Ltd.
|
India
|
-
|
28 September 2024
|
13 June 2028
|
| View |
|
DRP-13909-03
|
Cefixime (as trihydrate)
|
Maedix S
|
100 mg/ 5 mL
|
Powder for Suspension
|
Antibacterial
|
Medisure Laboratories Pakistan (Pvt.) Limited
|
Pakistan
|
CLIDP Conversion
|
15 September 2024
|
13 April 2025
|
| View |
|
DRP-14044-01
|
Sorafenib (as Tosylate)
|
Binefaros
|
200 mg
|
Film-Coated Tablet
|
Antineoplastic (Protein kinase inhibitor)
|
BDR Pharmaceuticals International Pvt. Ltd.
|
India
|
CLIDP Conversion
|
15 September 2024
|
08 June 2028
|
| View |
|
DRP-14065-06
|
Ceftriaxone (as sodium)
|
Trizon
|
1 g
|
Powder for Injection (IM/IV)
|
Antibacterial (Cephalosporin)
|
Swiss Parenterals Ltd.
|
India
|
CLIDP Conversion
|
24 September 2024
|
13 June 2028
|
| View |
|
DRP-13836-02
|
Letrozole
|
Ovupic
|
2.5 mg
|
Film-Coated Tablet
|
Aromatase Inhibitor
|
Bruck Pharma Private Limited
|
India
|
CLIDP Conversion
|
28 September 2024
|
08 February 2028
|
| View |
|
DRP-14150-01
|
Fluconazole
|
Ziludex-200
|
200 mg
|
Capsule
|
Antimycotic for systemic use (Triazole and Tetrazole Derivative)
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
24 September 2024
|
30 June 2028
|
| View |
|
DRP-14872-01
|
Bilastine
|
Blazen
|
20 mg
|
Tablet
|
Antihistamine
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
27 September 2024
|
26 January 2029
|
| View |
|
DRP-14375-11
|
Dutasteride + Tamsulosin Hydrochloride
|
Tamduet
|
500 mcg/400 mcg
|
Capsule
|
Benign Prostatic Hypertrophy Drug (Alpha-Adrenoreceptor Antagonist)
|
Pell Tech Health Care Private Ltd.
|
India
|
CLIDP Conversion
|
24 September 2024
|
31 October 2028
|
| View |
|
DRP-14239-02
|
Pantoprazole (as sodium sesquihydrate)
|
Protonel
|
40 mg
|
Lyophilized Powder for Injection (IV)
|
Proton Pump Inhibitor
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
27 September 2024
|
02 August 2028
|
| View |
|
DRP-14393-01
|
Telmisartan + Amlodipine (as besilate)
|
None
|
40 mg/5 mg
|
Tablet
|
Angiotensin II Receptor Blocker (ARB) / Calcium Channel Blocker
|
Lloyd Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
28 September 2024
|
31 August 2028
|
| View |
|
DRP-14853-03
|
Metformin Hydrochloride
|
Glumelife
|
500 mg
|
Film-Coated Tablet
|
Oral Hypoglycemic
|
Hebei Tiancheng Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
15 September 2024
|
26 May 2025
|
| View |
|
DRP-14170-03
|
Enzalutamide
|
Anezal
|
40 mg
|
Capsule
|
Androgen Receptor Antagonist
|
Globela Pharma Private Limited
|
India
|
CLIDP Conversion
|
27 September 2024
|
01 August 2028
|
| View |
|
DRP-14934-03
|
Letrozole
|
Wanda
|
2.5 mg
|
Film-Coated Tablet
|
Antineoplastic
|
Globela Pharma Private Limited
|
India
|
CLIDP Conversion
|
27 September 2024
|
26 February 2029
|
| View |
|
DRP-14658-03
|
Aripiprazole
|
Arpipo
|
10 mg
|
Orodispersible Tablet
|
Antipsychotic
|
Nobel Ilac Sanayii ve Ticaret A.S.
|
Turkey
|
CLIDP Conversion
|
29 September 2024
|
17 November 2028
|
| View |
|
DRP-14223-01
|
Ascorbic Acid + Zinc
|
None
|
100 mg (equivalent to 112.5 mg Sodium Ascorbate) / 10 mg (equivalent to 27.5 mg Zinc Sulfate Monohydrate) per 5 mL Oral
|
Syrup
|
Vitamin and Mineral
|
St. Martin Pharm Lab Co.
|
Philippines
|
CLIDP Conversion
|
15 September 2024
|
30 January 2027
|